'Cancer precision medicine drugs' presentation slideshows

Precision Medicine Market Size, 2018-2028

A recent survey conducted by the Tufts Center on the drug development, states that XX% of the drugs that are in the development pipeline include specific biomarkers in their research design. In addition, several biopharmaceutical companies have also increased their investments in precision medicine in the last five years, and the investments are expected to increase at least by another XX% by the next five years. Further, the scientific development and advancements in genomic sequencing, immunotherapy, gene therapy, and disease susceptibility are also expected to boost the precision medicine market in near future.

152 views • 14 slides